Not Yet Recruiting
Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma
NCT07542912
- Conditions
- Adverse Event, Complete Remission Rate， CRR, Duration of Response, +8 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, China